Ocrevus ocrelizuman 300mg/10ml injection

Ocrevus 300mg/10mL Injection contains Ocrelizumab, a monoclonal antibody used to treat certain forms of multiple sclerosis. It targets CD20-positive B cells, which are involved in the immune response associated with MS.

Key Information

• Active Ingredient: Ocrelizumab
• Strength: 300mg/10mL
• Manufacturer: Roche
• Uses: Used for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adults.
• Administration: Administered by intravenous infusion under the supervision of a qualified healthcare professional.
• Common Side Effects: Infusion or injection reactions and upper or lower respiratory tract infections may occur.
• Important: Ocrelizumab treatment requires medical monitoring due to the risk of serious infections and other adverse reactions.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before starting or changing any medication.